Biofeedback Vs Electrical Stimulation in Treatment of Fecal Incontinence

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT04380571
Collaborator
(none)
93
1
3
11.9
7.8

Study Details

Study Description

Brief Summary

Fecal incontinence is one of the most psychological frustrating problems. It occurs in children due to many causes. There is a wide range of non-invasive therapeutic approaches like Kegel exercise, Biofeedback, and posterior tibial nerve stimulation. However, up till now, there are no established guidelines for treatment.

the objective of this study is to evaluate and compare the early effect of Biofeedback therapy versus bilateral transcutaneous posterior tibial nerve stimulation (TPNS) as non-invasive methods in the treatment of functional non-retentive fecal incontinence (FNRFI) in children.

Condition or Disease Intervention/Treatment Phase
  • Device: Biofeedback
  • Device: Electrical stimulation
  • Other: Traditional treatment
N/A

Detailed Description

Functional non-retentive fecal incontinence (FNRFI) requires prolonged treatment with a wide range of non-invasive therapeutic approaches like Kegel exercise, Biofeedback, and posterior tibial nerve stimulation (PTNS). However, up till now, there are no established guidelines for treatment.1 The aim of this study is to evaluate and compare the early effect of Biofeedback therapy versus bilateral transcutaneous posterior tibial nerve stimulation (TPTNS) as non-invasive methods in the treatment of (FNRFI) in children.

Methodology: The current prospective randomized controlled study included 93 children with FNRFI who were randomly divided and allocated into three groups. Group A treated by conventional methods through dietetic regulation and Kegal exercises. Group B treated by biofeedback therapy while group C received bilateral (TPTNS). Initial manometric findings including resting pressure, squeeze pressure, 1st sensation, 1st urge, and intense urge were recorded and repeated after 3 and 6 months together with incontinence score recorded in using St' Mark's (Varizey) with the primary endpoint of improvement of the incontinence score more than 50%.

Study Design

Study Type:
Interventional
Actual Enrollment :
93 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The current prospective randomized controlled study included 93 children with FNRFI who were randomly divided and allocated into 3 groups. were managed by conventional methods through Kegal exercises and dietetic regulation where they had received bulky food including vegetables, fruits bran and cereals. Fast foods, spicy drinks and caffeine should be limited in child's diet. Local hygiene and zinc oxide application to the perianal skin were advised to prevent skin excoriation.Biofeedback group treated by biofeedback therapy in addition to traditional treatment, while the third group is the electrical stimulation group received bilateral (TPTNS) in addition to the traditional treatment. Initial manometric findings including resting pressure (mm hg), squeeze pressure (mm hg), 1st sensation (cm water), 1st urge (cm water), and intense urge (cm water) were recorded and repeated after 3 and 6 months together with incontinence score recorded in using St' Mark's (Varizey).The current prospective randomized controlled study included 93 children with FNRFI who were randomly divided and allocated into 3 groups. were managed by conventional methods through Kegal exercises and dietetic regulation where they had received bulky food including vegetables, fruits bran and cereals. Fast foods, spicy drinks and caffeine should be limited in child's diet. Local hygiene and zinc oxide application to the perianal skin were advised to prevent skin excoriation.Biofeedback group treated by biofeedback therapy in addition to traditional treatment, while the third group is the electrical stimulation group received bilateral (TPTNS) in addition to the traditional treatment. Initial manometric findings including resting pressure (mm hg), squeeze pressure (mm hg), 1st sensation (cm water), 1st urge (cm water), and intense urge (cm water) were recorded and repeated after 3 and 6 months together with incontinence score recorded in using St' Mark's (Varizey).
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Biofeedback Versus Bilateral Transcutaneous Electrical Nerve Stimulation in the Treatment of Functional Non-retentive Fecal Incontinence
Actual Study Start Date :
Mar 4, 2018
Actual Primary Completion Date :
Dec 27, 2018
Actual Study Completion Date :
Feb 28, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Biofeedback

Biofeedback therapy in addition to the conventional measures done in the control Group. It was performed in the same position used for baseline manometry. The used protocol included strength and sensory training, twice weekly for 3 months. Strength training was performed by a double-lumen rectal PVC balloon clothed catheter (MMS U-72210).

Device: Biofeedback
Biofeedback therapy in addition to the conventional measures done in the control Group. It was performed in the same position used for baseline manometry. The used protocol included strength and sensory training, twice weekly for 3 months. Strength training was performed by a double-lumen rectal PVC balloon clothed catheter (MMS U-72210).

Experimental: Electrical Stimulation

Bilateral (TPTNS); was applied with an electrode above the medial malleolus A second electrode) was applied just below the same malleolus. Electrical stimulation with a low-frequency current (10 Hz), and adjustable intensity. The procedure was done for 20-30 minutes, three times per week for 3 months together with the conventional maneuvers applied in the control group.

Device: Electrical stimulation
A positive auto adhesive electrode was applied above the medial malleolus over the S3 dermatome. A second negative electrode was applied just below the same malleolus. Both electrodes were linked to an electrical stimulation device ( EMS physio Ltd, OX129 F, England) with a low frequency current (10 Hz), and adjustable intensity.
Other Names:
  • Posterior tibial nerve stimulation
  • Active Comparator: Control group

    were managed by conventional methods through Kegal exercises and dietetic regulation where they had received bulky food including vegetables, fruits bran and cereals. Fast foods, spicy drinks and caffeine should be limited in child's diet. Local hygiene and zinc oxide application to the perianal skin were advised to prevent skin excoriation.

    Other: Traditional treatment
    Conventional treatment through Kegal exercises and dietetic regulation where they had received bulky food including vegetables, fruits bran and cereals. Fast foods, spicy drinks and caffeine should be limited in child's diet. Local hygiene and zinc oxide application to the perianal skin were advised to prevent skin excoriation.
    Other Names:
  • Exercises
  • Outcome Measures

    Primary Outcome Measures

    1. Incontinence score using St' Mark's (Vaiszey) [3 months after intervention]

      Questionnaire ranging from zero (indicating complete continence) to 24 (indicating total incontinence).

    2. incontinence score using St' Mark's (Vaiszey) [6 months after intervention]

      Questionnaire ranging from zero (indicating complete continence) to 24 (indicating total incontinence).

    Secondary Outcome Measures

    1. Resting pressure (mm hg) [3 months after intervention]

      Pressure during relaxation of the anal sphincter

    2. Resting pressure (mm hg) [6 months after intervention]

      Pressure during relaxation of the anal sphincter

    3. Squeeze pressure (mm hg) [3 months after intervention]

      Pressure during contraction of the anal sphincter

    4. Squeeze pressure (mm hg) [6 months after intervention]

      Pressure during contraction of the anal sphincter

    5. First sensation (volume of the balloon by cm water) [3 months after intervention]

      First sensation of the stool in the rectum

    6. First sensation (volume of the balloon by cm water) [6 months after intervention]

      First sensation of the stool in the rectum

    7. First Urge(volume of the balloon by cm water) [3 months after intervention]

      The patient is trying to hold defecation and he can

    8. First Urge(volume of the balloon by cm water) [6 months after intervention]

      The patient is trying to hold defecation and he can

    9. Intense urge (volume of the balloon by cm water) [3 months after intervention]

      The Patent can no longer control the defecation

    10. Intense urge (volume of the balloon by cm water) [6 months after intervention]

      the Patent can no longer control the defecation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 15 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • FecaI incontinence

    • Normal defecation frequency,

    • Normal bowel habits and

    • Normal stool consistency

    Exclusion Criteria:
    • Children who are not cooperative,

    • Children with traumatic sphincter injury,

    • Children with fecal impaction,

    • Children with spinal diseases causing incontinence,

    • Children with anorectal malformation,

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Banha University Banhā Banha Egypt 13518

    Sponsors and Collaborators

    • Cairo University

    Investigators

    • Principal Investigator: Emad M Abdelrhman, PhD, Benha University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Olfat Ibrahim Ali, Assistant professor, Cairo University
    ClinicalTrials.gov Identifier:
    NCT04380571
    Other Study ID Numbers:
    • Fecal incontinence
    First Posted:
    May 8, 2020
    Last Update Posted:
    May 8, 2020
    Last Verified:
    May 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Olfat Ibrahim Ali, Assistant professor, Cairo University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 8, 2020